Skip to main content
ADPT logo
ADPT
(NASDAQ)
Adaptive Biotechnologies Corporation
$13.96-- (--)
Loading... - Market loading

Adaptive Biotechnologies (ADPT) Stock Price & Financial Analysis

Adaptive Biotechnologies Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.92 - $13.99
52-Week High$20.76
52-Week Low$8.50
Open$13.05
Volume1.92M
Average Volume (3M)1.69M
Market Cap1.97B
Shares Outstanding151.72M
Price to Sales (P/S)7.10
Price to Book (P/B)8.74
EV/EBITDA-54.58
Revenue (TTM)276.98M
Net Income (TTM)-59.50M
Free Cash Flow (TTM)-48.95M
EPS (TTM)$-0.39
Profit Margin-21.48%
Operating Margin-20.62%
Return on Equity (ROE)-26.44%
Debt to Equity0.58
50-Day MA$14.08
200-Day MA$15.02
52-Week Change42.38%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Adaptive Biotechnologies

What is the current stock price for ADPT?

As of the latest trading session, ADPT stock trades at $13.96. The 52-week range is $8.50–$20.76, with a day range of $12.91–$13.99.

What is the P/E ratio for ADPT?

The P/E ratio (Price-to-Earnings) for ADPT is shown in the Key Statistics section. This valuation metric helps compare Adaptive Biotechnologies Corporation to industry peers.

Does ADPT pay dividends?

Adaptive Biotechnologies does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ADPT?

Analyst ratings and recommendations for ADPT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ADPT?

Adaptive Biotechnologies's market capitalization is $2.12B, classifying it as a mid-cap company..